stars 1 stars 2 stars 3

MPM BioImpact is a world-leading biotechnology investment firm with nearly three decades of experience creating and investing in companies that seek to translate scientific innovations into cures for major diseases. With its world-class team and deep experience in scientific research, clinical development, and company-building, MPM BioImpact strives to power novel medical breakthroughs that transform patients’ lives. MPM BioImpact invests across the biotech landscape from early stage start-ups to public companies.

MPM BioImpact Questions

The MPM BioImpact annual revenue was $6.8 million in 2026.

Christopher Wolf is the CFO of MPM BioImpact.

58 people are employed at MPM BioImpact.

MPM BioImpact is based in Boston, Massachusetts.

The NAICS codes for MPM BioImpact are [5239, 52, 523].

The SIC codes for MPM BioImpact are [679, 67].

Top MPM BioImpact Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users